{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:42:22Z","timestamp":1698500542138},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4015,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Genetics"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p>Gaucher disease (GD) is frequently associated with reduced plasma levels of low density lipoproteins, presumably due to increased catabolism of LDL. The purpose of this study was to determine the distribution of Tc\u201099m LDL (Tc\u2010LDL) in Gaucher patients, and compare the findings to bone marrow distribution. Four patients with non\u2010neuropathic Gaucher disease (type 1) underwent baseline whole body imaging at 4 and 24 h after injection of dialyzed autologous LDL labeled with 10\u201320 mCi Tc\u201099m\u2010pertechnetate. Three of the four patients were treated with macrophage\u2010targeted alglucerase (Ceredase). The LDL studies were compared to concurrent bone marrow scans performed with 10 mCi Tc\u201099m sulfur colloid (Tc\u2010SC). Follow\u2010up Tc\u2010LDL and Tc\u2010SC scans were obtained 12\u201314 months later. Tc\u2010LDL activity was abnormally increased in the spleen and long bones of the upper and lower extremities. Liver activity was also increased. Prominent blood pool activity 4 h after injection mostly cleared on the 24\u2010hour images. The distribution of Tc\u2010SC was congruent with Tc\u2010LDL activity. All patients had mild\u2010to\u2010moderate hepatomegaly and peripheral bone marrow expansion. One patient had been previously splenectomized and the remaining three had moderate\u2010to\u2010severe splenomegaly. Two of the three treated patients showed regression of peripheral bone marrow activity with therapy, along with a comparable decrease in Tc\u2010LDL uptake. Our study with Tc\u2010LDL and Tc\u2010SC suggests that in patients with Gaucher disease native LDL is taken up by the reticuloendothelial system (RES) of the spleen and bone marrow in addition to increased uptake by the liver. This abnormal uptake (presumably by macrophages of the RES) may account for accelerated LDL catabolism and reduced plasma levels of LDL. Serial LDL studies can be performed, allowing for longitudinal follow\u2010up after drug or enzyme therapies.<\/jats:p>","DOI":"10.1111\/j.1399-0004.1997.tb02507.x","type":"journal-article","created":{"date-parts":[[2010,7,19]],"date-time":"2010-07-19T11:22:01Z","timestamp":1279538521000},"page":"7-11","source":"Crossref","is-referenced-by-count":6,"title":["Scintigraphic evaluation of Tc\u201099m\u2010low\u2010density lipoprotein (LDL) distribution in patients with Gaucher disease"],"prefix":"10.1111","volume":"52","author":[{"given":"Mordechai","family":"Lorberboym","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shankar","family":"Vallabhajosula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Lipszyc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.9.3178"},{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111044"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-3-311"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.10.2.256"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1984.tb00799.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.3.3.233"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.46.070177.004341"},{"key":"e_1_2_1_8_1","first-page":"672","volume-title":"The metabolic basis of inherited disease","author":"Goldstein JL","year":"1983"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110849"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(88)90102-3"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.8.5.461"},{"key":"e_1_2_1_12_1","first-page":"1056","article-title":"Technetium\u201099m low density lipoproteins: preparation and biodistribution","volume":"26","author":"Lees RS","year":"1985","journal-title":"J Nucl Med"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00181757"},{"key":"e_1_2_1_14_1","article-title":"Scintigraphic monitoring of patients with type 1 Gaucher disease on enzyme replacement therapy","author":"Lorberboym M","year":"1997","journal-title":"J Nucl Med"},{"key":"e_1_2_1_15_1","first-page":"141","article-title":"Residualizing and non\u2010residualizing analogues of low density lipoprotein as I\u2010123 radiopharmaceuticals for imaging LDL catabolism","volume":"15","author":"Moerlein SM","year":"1988","journal-title":"Nucl Med Biol"},{"key":"e_1_2_1_16_1","unstructured":"PastoresGM BerglundL DesnickRJ.Lipoprotein metabolism in type I Gaucher disease patients on enzyme therapy. Abstract American Federation of Clinical Researchers Meeting 1996."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2120791"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910540311"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1542\/peds.96.4.629","article-title":"Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage\u2010 targeted glucocere\u2010brosidase","volume":"96","author":"Rosenthal DI","year":"1995","journal-title":"Pediatrics"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-2998(05)80177-1"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0004.1997.tb02507.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0004.1997.tb02507.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T20:32:27Z","timestamp":1698438747000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0004.1997.tb02507.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1111\/j.1399-0004.1997.tb02507.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0004.1997.tb02507.x","archive":["Portico"],"relation":{},"ISSN":["0009-9163","1399-0004"],"issn-type":[{"value":"0009-9163","type":"print"},{"value":"1399-0004","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}